

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 6.53001712 |
| 2 | drug catabolic process (GO:0042737) | 5.86925571 |
| 3 | blood coagulation, intrinsic pathway (GO:0007597) | 5.74794606 |
| 4 | axonemal dynein complex assembly (GO:0070286) | 4.98018109 |
| 5 | ethanol metabolic process (GO:0006067) | 4.88082757 |
| 6 | cellular glucuronidation (GO:0052695) | 4.82735126 |
| 7 | complement activation, alternative pathway (GO:0006957) | 4.66322008 |
| 8 | omega-hydroxylase P450 pathway (GO:0097267) | 4.55364512 |
| 9 | glucuronate metabolic process (GO:0019585) | 4.50150177 |
| 10 | uronic acid metabolic process (GO:0006063) | 4.50150177 |
| 11 | primary alcohol catabolic process (GO:0034310) | 4.34688705 |
| 12 | negative regulation of sterol transport (GO:0032372) | 4.31504027 |
| 13 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.22085265 |
| 14 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.21609131 |
| 15 | negative regulation of fibrinolysis (GO:0051918) | 4.21541631 |
| 16 | apoptotic cell clearance (GO:0043277) | 4.19905131 |
| 17 | * regulation of protein activation cascade (GO:2000257) | 4.18857999 |
| 18 | * peptidyl-glutamic acid carboxylation (GO:0017187) | 4.14229391 |
| 19 | * protein carboxylation (GO:0018214) | 4.14229391 |
| 20 | * regulation of complement activation (GO:0030449) | 4.10791802 |
| 21 | * negative regulation of coagulation (GO:0050819) | 4.08209152 |
| 22 | drug metabolic process (GO:0017144) | 3.99049877 |
| 23 | negative regulation of complement activation (GO:0045916) | 3.98730745 |
| 24 | * negative regulation of wound healing (GO:0061045) | 3.92782395 |
| 25 | low-density lipoprotein particle remodeling (GO:0034374) | 3.89303158 |
| 26 | negative regulation of humoral immune response (GO:0002921) | 3.82382892 |
| 27 | regulation of fibrinolysis (GO:0051917) | 3.78972807 |
| 28 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.77975914 |
| 29 | intestinal cholesterol absorption (GO:0030299) | 3.67726408 |
| 30 | * regulation of humoral immune response (GO:0002920) | 3.67317745 |
| 31 | tyrosine metabolic process (GO:0006570) | 3.65223949 |
| 32 | alpha-linolenic acid metabolic process (GO:0036109) | 3.59631960 |
| 33 | urea metabolic process (GO:0019627) | 3.51467304 |
| 34 | urea cycle (GO:0000050) | 3.51467304 |
| 35 | doxorubicin metabolic process (GO:0044598) | 3.51123143 |
| 36 | daunorubicin metabolic process (GO:0044597) | 3.51123143 |
| 37 | polyketide metabolic process (GO:0030638) | 3.51123143 |
| 38 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.50457524 |
| 39 | L-phenylalanine metabolic process (GO:0006558) | 3.50457524 |
| 40 | negative regulation of lipase activity (GO:0060192) | 3.50025355 |
| 41 | cell adhesion mediated by integrin (GO:0033627) | 3.48698509 |
| 42 | L-phenylalanine catabolic process (GO:0006559) | 3.47794039 |
| 43 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.47794039 |
| 44 | basement membrane organization (GO:0071711) | 3.46692691 |
| 45 | plasma lipoprotein particle assembly (GO:0034377) | 3.45125485 |
| 46 | cilium movement (GO:0003341) | 3.41490161 |
| 47 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.40620345 |
| 48 | positive regulation of extracellular matrix organization (GO:1903055) | 3.38549901 |
| 49 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.35840539 |
| 50 | motile cilium assembly (GO:0044458) | 3.34268353 |
| 51 | low-density lipoprotein particle clearance (GO:0034383) | 3.33653737 |
| 52 | plasma lipoprotein particle clearance (GO:0034381) | 3.32744239 |
| 53 | sulfur amino acid catabolic process (GO:0000098) | 3.31420086 |
| 54 | plasma lipoprotein particle organization (GO:0071827) | 3.31417327 |
| 55 | high-density lipoprotein particle remodeling (GO:0034375) | 3.28756276 |
| 56 | opsonization (GO:0008228) | 3.27883462 |
| 57 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.26739781 |
| 58 | bile acid biosynthetic process (GO:0006699) | 3.22299266 |
| 59 | response to mercury ion (GO:0046689) | 3.22208823 |
| 60 | positive regulation of blood coagulation (GO:0030194) | 3.21510411 |
| 61 | positive regulation of hemostasis (GO:1900048) | 3.21510411 |
| 62 | complement activation (GO:0006956) | 3.21276013 |
| 63 | oxidative demethylation (GO:0070989) | 3.20933912 |
| 64 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.20736084 |
| 65 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.20736084 |
| 66 | collagen fibril organization (GO:0030199) | 3.20454199 |
| 67 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.20084700 |
| 68 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.18659740 |
| 69 | reverse cholesterol transport (GO:0043691) | 3.16258570 |
| 70 | hormone catabolic process (GO:0042447) | 3.16251989 |
| 71 | homocysteine metabolic process (GO:0050667) | 3.15756958 |
| 72 | protein-lipid complex subunit organization (GO:0071825) | 3.15169567 |
| 73 | regulation of apoptotic cell clearance (GO:2000425) | 3.14691210 |
| 74 | epoxygenase P450 pathway (GO:0019373) | 3.13945306 |
| 75 | nitrogen cycle metabolic process (GO:0071941) | 3.13871512 |
| 76 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.13092754 |
| 77 | primary alcohol metabolic process (GO:0034308) | 3.11867349 |
| 78 | aromatic amino acid family catabolic process (GO:0009074) | 3.11740242 |
| 79 | phenylpropanoid metabolic process (GO:0009698) | 3.11471247 |
| 80 | regulation of lipoprotein metabolic process (GO:0050746) | 3.11324622 |
| 81 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.07795330 |
| 82 | * fibrinolysis (GO:0042730) | 3.04317044 |
| 83 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.03078712 |
| 84 | regulation of cholesterol storage (GO:0010885) | 3.03015602 |
| 85 | positive regulation of coagulation (GO:0050820) | 3.02886095 |
| 86 | positive regulation of wound healing (GO:0090303) | 3.02371166 |
| 87 | protein heterotrimerization (GO:0070208) | 3.02079282 |
| 88 | glyoxylate metabolic process (GO:0046487) | 3.01577845 |
| 89 | carnitine metabolic process (GO:0009437) | 3.01388980 |
| 90 | complement activation, classical pathway (GO:0006958) | 2.99211031 |
| 91 | negative regulation of lipid transport (GO:0032369) | 2.97750906 |
| 92 | * regulation of blood coagulation (GO:0030193) | 2.97407411 |
| 93 | protein activation cascade (GO:0072376) | 2.97326965 |
| 94 | phospholipid efflux (GO:0033700) | 2.94667421 |
| 95 | endodermal cell differentiation (GO:0035987) | 2.93293834 |
| 96 | regulation of triglyceride catabolic process (GO:0010896) | 2.89787388 |
| 97 | regulation of plasminogen activation (GO:0010755) | 2.88685577 |
| 98 | kynurenine metabolic process (GO:0070189) | 2.86555316 |
| 99 | phospholipid homeostasis (GO:0055091) | 2.82915573 |
| 100 | lipoprotein metabolic process (GO:0042157) | 2.82501994 |
| 101 | negative regulation of protein activation cascade (GO:2000258) | 2.82435325 |
| 102 | protein-lipid complex remodeling (GO:0034368) | 2.78805667 |
| 103 | macromolecular complex remodeling (GO:0034367) | 2.78805667 |
| 104 | plasma lipoprotein particle remodeling (GO:0034369) | 2.78805667 |
| 105 | tryptophan catabolic process (GO:0006569) | 2.78229117 |
| 106 | indole-containing compound catabolic process (GO:0042436) | 2.78229117 |
| 107 | indolalkylamine catabolic process (GO:0046218) | 2.78229117 |
| 108 | keratan sulfate catabolic process (GO:0042340) | 2.77853749 |
| 109 | tryptophan metabolic process (GO:0006568) | 2.72830782 |
| 110 | bile acid metabolic process (GO:0008206) | 2.72310710 |
| 111 | positive regulation of lipid catabolic process (GO:0050996) | 2.70811739 |
| 112 | positive regulation of p38MAPK cascade (GO:1900745) | 2.70794844 |
| 113 | glomerular basement membrane development (GO:0032836) | 2.70662662 |
| 114 | positive regulation of fatty acid oxidation (GO:0046321) | 2.70184539 |
| 115 | cysteine metabolic process (GO:0006534) | 2.69310632 |
| 116 | cholesterol efflux (GO:0033344) | 2.68421584 |
| 117 | regulation of cholesterol esterification (GO:0010872) | 2.67724228 |
| 118 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.67655455 |
| 119 | triglyceride homeostasis (GO:0070328) | 2.67545039 |
| 120 | acylglycerol homeostasis (GO:0055090) | 2.67545039 |
| 121 | midgut development (GO:0007494) | 2.65561012 |
| 122 | amino-acid betaine metabolic process (GO:0006577) | 2.64958169 |
| 123 | collagen metabolic process (GO:0032963) | 2.63976623 |
| 124 | glomerular visceral epithelial cell development (GO:0072015) | 2.63462708 |
| 125 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.61248261 |
| 126 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.60197614 |
| 127 | endothelial cell morphogenesis (GO:0001886) | 2.60158186 |
| 128 | acute-phase response (GO:0006953) | 2.59066029 |
| 129 | bile acid and bile salt transport (GO:0015721) | 2.57958110 |
| 130 | lysine metabolic process (GO:0006553) | 2.57955452 |
| 131 | lysine catabolic process (GO:0006554) | 2.57955452 |
| 132 | * negative regulation of blood coagulation (GO:0030195) | 2.57769843 |
| 133 | * negative regulation of hemostasis (GO:1900047) | 2.57769843 |
| 134 | blood vessel endothelial cell migration (GO:0043534) | 2.55430292 |
| 135 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.54832882 |
| 136 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.53559071 |
| 137 | skin morphogenesis (GO:0043589) | 2.53256959 |
| 138 | wound healing, spreading of epidermal cells (GO:0035313) | 2.53191793 |
| 139 | collagen catabolic process (GO:0030574) | 2.52272010 |
| 140 | lymph vessel development (GO:0001945) | 2.50170649 |
| 141 | regulation of cholesterol homeostasis (GO:2000188) | 2.47747050 |
| 142 | lymphangiogenesis (GO:0001946) | 2.47199666 |
| 143 | protein-lipid complex assembly (GO:0065005) | 2.47061321 |
| 144 | ethanol oxidation (GO:0006069) | 2.46972792 |
| 145 | cholesterol homeostasis (GO:0042632) | 2.46274502 |
| 146 | sterol homeostasis (GO:0055092) | 2.45875108 |
| 147 | negative regulation of cholesterol transport (GO:0032375) | 2.44909000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.40998726 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.64279559 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.28002756 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.09224011 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.06291568 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.00004028 |
| 7 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.90685678 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.44785619 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.27180186 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.13465620 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.94704974 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.93691230 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.68621679 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.57615753 |
| 15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.45472376 |
| 16 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.21420005 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.14877867 |
| 18 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.14330355 |
| 19 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.12285486 |
| 20 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.08067979 |
| 21 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.07142610 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.01139604 |
| 23 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.99259477 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.86462456 |
| 25 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.83086194 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.80787991 |
| 27 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.77814587 |
| 28 | CJUN_26792858_Chip-Seq_BT549_Human | 1.76726149 |
| 29 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.73670146 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.71709071 |
| 31 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.69510030 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.68144257 |
| 33 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.67280263 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.65923954 |
| 35 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.65084070 |
| 36 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.64144741 |
| 37 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.59487786 |
| 38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.58465330 |
| 39 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.58009349 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.55600236 |
| 41 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.54153463 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50644322 |
| 43 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.50507054 |
| 44 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.49449712 |
| 45 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.49449712 |
| 46 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.49333881 |
| 47 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.45345035 |
| 48 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.44862851 |
| 49 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.42926179 |
| 50 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37519580 |
| 51 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37427372 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37296970 |
| 53 | GATA1_19941826_ChIP-Seq_K562_Human | 1.35922821 |
| 54 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.35137544 |
| 55 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.34807719 |
| 56 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.33996359 |
| 57 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.33521258 |
| 58 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.31896212 |
| 59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.31452071 |
| 60 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.29768019 |
| 61 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.26259411 |
| 62 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.25907617 |
| 63 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.23825219 |
| 64 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23520641 |
| 65 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.23433086 |
| 66 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.23273585 |
| 67 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.23273585 |
| 68 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.22973157 |
| 69 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.21200386 |
| 70 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.17023146 |
| 71 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.17023146 |
| 72 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.17023146 |
| 73 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.16870879 |
| 74 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.16835832 |
| 75 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16554264 |
| 76 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.16487343 |
| 77 | GATA2_19941826_ChIP-Seq_K562_Human | 1.15446785 |
| 78 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.13845441 |
| 79 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.13359238 |
| 80 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.12008250 |
| 81 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.09412673 |
| 82 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.09156824 |
| 83 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.07362174 |
| 84 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07089074 |
| 85 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06864863 |
| 86 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06034986 |
| 87 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.04283138 |
| 88 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.02163461 |
| 89 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.01354438 |
| 90 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.98638646 |
| 91 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.98462365 |
| 92 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98024403 |
| 93 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.97963950 |
| 94 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97626523 |
| 95 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97567509 |
| 96 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97364057 |
| 97 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97364057 |
| 98 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96484163 |
| 99 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96435351 |
| 100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96137473 |
| 101 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95004315 |
| 102 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93258985 |
| 103 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.89019356 |
| 104 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88498904 |
| 105 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.88321324 |
| 106 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.88082913 |
| 107 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87774083 |
| 108 | TP53_16413492_ChIP-PET_HCT116_Human | 0.87666370 |
| 109 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87612717 |
| 110 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.87094943 |
| 111 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.86716489 |
| 112 | ATF3_27146783_Chip-Seq_COLON_Human | 0.86247497 |
| 113 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86028763 |
| 114 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85544480 |
| 115 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84769286 |
| 116 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.84022391 |
| 117 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83850215 |
| 118 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.83583050 |
| 119 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.83493762 |
| 120 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.83439636 |
| 121 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.83421435 |
| 122 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.82817122 |
| 123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82621060 |
| 124 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.82097483 |
| 125 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.80790681 |
| 126 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.80737543 |
| 127 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.79261434 |
| 128 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.78895304 |
| 129 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.76774796 |
| 130 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.76189525 |
| 131 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.76183107 |
| 132 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76060351 |
| 133 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.75109923 |
| 134 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.75019338 |
| 135 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.74768875 |
| 136 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.72109721 |
| 137 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.72091003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.45673321 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 4.07913889 |
| 3 | MP0005275_abnormal_skin_tensile | 3.45537007 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.30793127 |
| 5 | MP0005360_urolithiasis | 3.30156401 |
| 6 | MP0004272_abnormal_basement_membrane | 2.75724853 |
| 7 | MP0010368_abnormal_lymphatic_system | 2.71839042 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 2.65732512 |
| 9 | MP0005503_abnormal_tendon_morphology | 2.49957130 |
| 10 | MP0003868_abnormal_feces_composition | 2.48723132 |
| 11 | MP0005365_abnormal_bile_salt | 2.47462165 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.41872673 |
| 13 | MP0003279_aneurysm | 2.41775347 |
| 14 | MP0009840_abnormal_foam_cell | 2.32834735 |
| 15 | MP0003252_abnormal_bile_duct | 2.26524580 |
| 16 | MP0005408_hypopigmentation | 2.24343020 |
| 17 | MP0002132_abnormal_respiratory_system | 2.16824620 |
| 18 | MP0003724_increased_susceptibility_to | 2.05793214 |
| 19 | MP0006054_spinal_hemorrhage | 2.05764108 |
| 20 | MP0009384_cardiac_valve_regurgitation | 2.00329295 |
| 21 | MP0001958_emphysema | 1.94765877 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 1.93339015 |
| 23 | MP0003566_abnormal_cell_adhesion | 1.85019179 |
| 24 | MP0010329_abnormal_lipoprotein_level | 1.80241158 |
| 25 | MP0005023_abnormal_wound_healing | 1.73758868 |
| 26 | MP0001879_abnormal_lymphatic_vessel | 1.71381739 |
| 27 | MP0009697_abnormal_copulation | 1.68298534 |
| 28 | MP0002060_abnormal_skin_morphology | 1.64372971 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.64183831 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.62977928 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.60130578 |
| 32 | MP0003806_abnormal_nucleotide_metabolis | 1.59056656 |
| 33 | MP0002254_reproductive_system_inflammat | 1.49224296 |
| 34 | MP0005058_abnormal_lysosome_morphology | 1.48421893 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.46941620 |
| 36 | MP0001661_extended_life_span | 1.42367087 |
| 37 | MP0005623_abnormal_meninges_morphology | 1.41653826 |
| 38 | MP0000566_synostosis | 1.37080201 |
| 39 | MP0002295_abnormal_pulmonary_circulatio | 1.36536504 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.35816572 |
| 41 | MP0003950_abnormal_plasma_membrane | 1.32109363 |
| 42 | MP0001542_abnormal_bone_strength | 1.30719615 |
| 43 | MP0000767_abnormal_smooth_muscle | 1.28989234 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.27303546 |
| 45 | MP0009053_abnormal_anal_canal | 1.26802491 |
| 46 | MP0005409_darkened_coat_color | 1.23180563 |
| 47 | MP0002138_abnormal_hepatobiliary_system | 1.23087412 |
| 48 | MP0000609_abnormal_liver_physiology | 1.21574278 |
| 49 | MP0004084_abnormal_cardiac_muscle | 1.18512907 |
| 50 | MP0005332_abnormal_amino_acid | 1.18419432 |
| 51 | MP0005508_abnormal_skeleton_morphology | 1.14830927 |
| 52 | MP0003091_abnormal_cell_migration | 1.14657707 |
| 53 | MP0000343_altered_response_to | 1.12573895 |
| 54 | MP0005670_abnormal_white_adipose | 1.12265324 |
| 55 | MP0004019_abnormal_vitamin_homeostasis | 1.09068154 |
| 56 | MP0003195_calcinosis | 1.07164307 |
| 57 | MP0005164_abnormal_response_to | 1.05184416 |
| 58 | MP0003436_decreased_susceptibility_to | 1.04807451 |
| 59 | MP0001243_abnormal_dermal_layer | 1.04054001 |
| 60 | MP0005167_abnormal_blood-brain_barrier | 1.03891987 |
| 61 | MP0005390_skeleton_phenotype | 1.00854434 |
| 62 | MP0002168_other_aberrant_phenotype | 0.99423517 |
| 63 | MP0003453_abnormal_keratinocyte_physiol | 0.97741794 |
| 64 | MP0005319_abnormal_enzyme/_coenzyme | 0.96827902 |
| 65 | MP0002118_abnormal_lipid_homeostasis | 0.96394675 |
| 66 | MP0002896_abnormal_bone_mineralization | 0.95919866 |
| 67 | MP0005187_abnormal_penis_morphology | 0.95439064 |
| 68 | MP0002998_abnormal_bone_remodeling | 0.93883256 |
| 69 | MP0004883_abnormal_blood_vessel | 0.93647511 |
| 70 | MP0006138_congestive_heart_failure | 0.93646463 |
| 71 | MP0006082_CNS_inflammation | 0.92843116 |
| 72 | MP0000249_abnormal_blood_vessel | 0.92497577 |
| 73 | * MP0001915_intracranial_hemorrhage | 0.92262020 |
| 74 | MP0004130_abnormal_muscle_cell | 0.91690857 |
| 75 | MP0005083_abnormal_biliary_tract | 0.91456080 |
| 76 | MP0003303_peritoneal_inflammation | 0.91367363 |
| 77 | MP0003011_delayed_dark_adaptation | 0.90973578 |
| 78 | MP0001666_abnormal_nutrient_absorption | 0.90210363 |
| 79 | MP0004185_abnormal_adipocyte_glucose | 0.89937469 |
| 80 | MP0002877_abnormal_melanocyte_morpholog | 0.87535331 |
| 81 | MP0005171_absent_coat_pigmentation | 0.87520455 |
| 82 | MP0009764_decreased_sensitivity_to | 0.86276330 |
| 83 | MP0003075_altered_response_to | 0.86123176 |
| 84 | MP0005257_abnormal_intraocular_pressure | 0.85865411 |
| 85 | MP0002282_abnormal_trachea_morphology | 0.85728064 |
| 86 | * MP0000598_abnormal_liver_morphology | 0.82777876 |
| 87 | MP0003136_yellow_coat_color | 0.81562463 |
| 88 | * MP0009763_increased_sensitivity_to | 0.81480881 |
| 89 | MP0005076_abnormal_cell_differentiation | 0.81347849 |
| 90 | MP0008775_abnormal_heart_ventricle | 0.81137274 |
| 91 | MP0001851_eye_inflammation | 0.81078950 |
| 92 | * MP0002128_abnormal_blood_circulation | 0.80744860 |
| 93 | MP0004947_skin_inflammation | 0.79234558 |
| 94 | MP0010234_abnormal_vibrissa_follicle | 0.78814555 |
| 95 | MP0005666_abnormal_adipose_tissue | 0.78114404 |
| 96 | MP0009643_abnormal_urine_homeostasis | 0.77817163 |
| 97 | MP0003045_fibrosis | 0.77320641 |
| 98 | MP0002108_abnormal_muscle_morphology | 0.76943746 |
| 99 | MP0003690_abnormal_glial_cell | 0.76519308 |
| 100 | MP0005636_abnormal_mineral_homeostasis | 0.76307467 |
| 101 | MP0002933_joint_inflammation | 0.75422702 |
| 102 | MP0009278_abnormal_bone_marrow | 0.75001210 |
| 103 | MP0005595_abnormal_vascular_smooth | 0.74997488 |
| 104 | MP0001614_abnormal_blood_vessel | 0.74990274 |
| 105 | MP0005165_increased_susceptibility_to | 0.74333709 |
| 106 | MP0008004_abnormal_stomach_pH | 0.74038111 |
| 107 | MP0003448_altered_tumor_morphology | 0.73963178 |
| 108 | MP0002796_impaired_skin_barrier | 0.73463873 |
| 109 | MP0004036_abnormal_muscle_relaxation | 0.73076804 |
| 110 | MP0000013_abnormal_adipose_tissue | 0.73009092 |
| 111 | MP0002166_altered_tumor_susceptibility | 0.72911795 |
| 112 | MP0003828_pulmonary_edema | 0.72369992 |
| 113 | MP0008469_abnormal_protein_level | 0.72079164 |
| 114 | MP0005395_other_phenotype | 0.71667606 |
| 115 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71554257 |
| 116 | MP0001764_abnormal_homeostasis | 0.71372769 |
| 117 | MP0002971_abnormal_brown_adipose | 0.70127546 |
| 118 | MP0002089_abnormal_postnatal_growth/wei | 0.70022307 |
| 119 | MP0005464_abnormal_platelet_physiology | 0.69442107 |
| 120 | * MP0009642_abnormal_blood_homeostasis | 0.68882984 |
| 121 | MP0002419_abnormal_innate_immunity | 0.67462242 |
| 122 | MP0005248_abnormal_Harderian_gland | 0.66326432 |
| 123 | MP0005197_abnormal_uvea_morphology | 0.65850154 |
| 124 | MP0002115_abnormal_skeleton_extremities | 0.65699492 |
| 125 | MP0005166_decreased_susceptibility_to | 0.65016779 |
| 126 | MP0003186_abnormal_redox_activity | 0.64727199 |
| 127 | MP0002135_abnormal_kidney_morphology | 0.64638862 |
| 128 | MP0000733_abnormal_muscle_development | 0.63855306 |
| 129 | MP0000465_gastrointestinal_hemorrhage | 0.63583314 |
| 130 | MP0002136_abnormal_kidney_physiology | 0.63009337 |
| 131 | MP0005330_cardiomyopathy | 0.62124016 |
| 132 | MP0000604_amyloidosis | 0.61932323 |
| 133 | MP0003941_abnormal_skin_development | 0.61300829 |
| 134 | MP0005376_homeostasis/metabolism_phenot | 0.60156257 |
| 135 | MP0000467_abnormal_esophagus_morphology | 0.59314598 |
| 136 | MP0002972_abnormal_cardiac_muscle | 0.56698947 |
| 137 | MP0000858_altered_metastatic_potential | 0.56083526 |
| 138 | MP0004215_abnormal_myocardial_fiber | 0.55252084 |
| 139 | MP0001984_abnormal_olfaction | 0.53066905 |
| 140 | MP0000751_myopathy | 0.53010921 |
| 141 | MP0001756_abnormal_urination | 0.52473791 |
| 142 | MP0005451_abnormal_body_composition | 0.49280255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 5.46483445 |
| 2 | Protrusio acetabuli (HP:0003179) | 5.37993220 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.06861068 |
| 4 | Complement deficiency (HP:0004431) | 5.04851640 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 4.95318253 |
| 6 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.91948563 |
| 7 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.91948563 |
| 8 | Premature rupture of membranes (HP:0001788) | 4.89779270 |
| 9 | Abnormal ciliary motility (HP:0012262) | 4.81842085 |
| 10 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.80418491 |
| 11 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.63937980 |
| 12 | Absent/shortened dynein arms (HP:0200106) | 4.63937980 |
| 13 | Rhinitis (HP:0012384) | 4.63776217 |
| 14 | Conjugated hyperbilirubinemia (HP:0002908) | 4.55923706 |
| 15 | Abnormality of complement system (HP:0005339) | 4.17034047 |
| 16 | Menorrhagia (HP:0000132) | 4.15961186 |
| 17 | Cerebral aneurysm (HP:0004944) | 4.12417226 |
| 18 | Glomerulonephritis (HP:0000099) | 4.02525968 |
| 19 | Aortic dissection (HP:0002647) | 3.82888296 |
| 20 | Peritonitis (HP:0002586) | 3.78876964 |
| 21 | Aortic aneurysm (HP:0004942) | 3.72928968 |
| 22 | Xanthomatosis (HP:0000991) | 3.70868402 |
| 23 | Broad metatarsal (HP:0001783) | 3.60770488 |
| 24 | Spontaneous abortion (HP:0005268) | 3.55059330 |
| 25 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.48935520 |
| 26 | Gingival bleeding (HP:0000225) | 3.48382469 |
| 27 | Increased mean platelet volume (HP:0011877) | 3.32291075 |
| 28 | Intrahepatic cholestasis (HP:0001406) | 3.32207270 |
| 29 | Shallow orbits (HP:0000586) | 3.31398291 |
| 30 | Myocardial infarction (HP:0001658) | 3.26500469 |
| 31 | Ankle contracture (HP:0006466) | 3.19214153 |
| 32 | Nephritis (HP:0000123) | 3.15886744 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 3.06973716 |
| 34 | Prolonged partial thromboplastin time (HP:0003645) | 3.04049696 |
| 35 | Abnormality of the common coagulation pathway (HP:0010990) | 3.00307081 |
| 36 | * Purpura (HP:0000979) | 2.97338071 |
| 37 | Cervical subluxation (HP:0003308) | 2.95124064 |
| 38 | Mitral valve prolapse (HP:0001634) | 2.89842991 |
| 39 | Soft skin (HP:0000977) | 2.88473695 |
| 40 | Abnormal platelet volume (HP:0011876) | 2.86506458 |
| 41 | Hyperlipoproteinemia (HP:0010980) | 2.85226860 |
| 42 | Joint hemorrhage (HP:0005261) | 2.83707371 |
| 43 | Chronic bronchitis (HP:0004469) | 2.83294430 |
| 44 | Atrophic scars (HP:0001075) | 2.82496358 |
| 45 | Hematochezia (HP:0002573) | 2.77651093 |
| 46 | Acanthocytosis (HP:0001927) | 2.77172635 |
| 47 | Mitral stenosis (HP:0001718) | 2.77067386 |
| 48 | Bronchiectasis (HP:0002110) | 2.75737959 |
| 49 | Nasal polyposis (HP:0100582) | 2.74399030 |
| 50 | Esophageal varix (HP:0002040) | 2.72997289 |
| 51 | Hypolipoproteinemia (HP:0010981) | 2.66310282 |
| 52 | Osteolytic defects of the hand bones (HP:0009699) | 2.65199199 |
| 53 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.65199199 |
| 54 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.63734237 |
| 55 | Vascular tortuosity (HP:0004948) | 2.62586489 |
| 56 | Rickets (HP:0002748) | 2.61556456 |
| 57 | Arterial tortuosity (HP:0005116) | 2.59207588 |
| 58 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.58380691 |
| 59 | Blue sclerae (HP:0000592) | 2.57872588 |
| 60 | Vertebral compression fractures (HP:0002953) | 2.53669878 |
| 61 | Nonimmune hydrops fetalis (HP:0001790) | 2.53364768 |
| 62 | Abnormality of the intrinsic pathway (HP:0010989) | 2.50402461 |
| 63 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.49757752 |
| 64 | Prolonged bleeding time (HP:0003010) | 2.49735127 |
| 65 | Hypobetalipoproteinemia (HP:0003563) | 2.49341249 |
| 66 | Dilatation of the ascending aorta (HP:0005111) | 2.49194496 |
| 67 | Aneurysm (HP:0002617) | 2.49179363 |
| 68 | Cardiovascular calcification (HP:0011915) | 2.48690295 |
| 69 | Abnormality of the nasal mucosa (HP:0000433) | 2.45120308 |
| 70 | Epistaxis (HP:0000421) | 2.42686300 |
| 71 | Steatorrhea (HP:0002570) | 2.41190484 |
| 72 | Follicular hyperkeratosis (HP:0007502) | 2.37503483 |
| 73 | Poikilocytosis (HP:0004447) | 2.36852104 |
| 74 | Increased connective tissue (HP:0009025) | 2.32877712 |
| 75 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.32361244 |
| 76 | Epidermoid cyst (HP:0200040) | 2.31445710 |
| 77 | Osteomalacia (HP:0002749) | 2.29590859 |
| 78 | Bladder diverticulum (HP:0000015) | 2.24576347 |
| 79 | Male infertility (HP:0003251) | 2.24180543 |
| 80 | Skin nodule (HP:0200036) | 2.23879438 |
| 81 | Striae distensae (HP:0001065) | 2.20261510 |
| 82 | Impaired platelet aggregation (HP:0003540) | 2.19220605 |
| 83 | Abnormal platelet function (HP:0011869) | 2.19220605 |
| 84 | Abnormal delivery (HP:0001787) | 2.16399303 |
| 85 | Spondylolisthesis (HP:0003302) | 2.12675671 |
| 86 | Hydroxyprolinuria (HP:0003080) | 2.12268445 |
| 87 | Abnormality of proline metabolism (HP:0010907) | 2.12268445 |
| 88 | Wrist flexion contracture (HP:0001239) | 2.10815952 |
| 89 | Biconcave vertebral bodies (HP:0004586) | 2.10306501 |
| 90 | Alopecia of scalp (HP:0002293) | 2.09907317 |
| 91 | Fragile skin (HP:0001030) | 2.09538030 |
| 92 | Lymphangioma (HP:0100764) | 2.09530967 |
| 93 | Polycythemia (HP:0001901) | 2.09122332 |
| 94 | Wormian bones (HP:0002645) | 2.08755865 |
| 95 | Ectopia lentis (HP:0001083) | 2.07652560 |
| 96 | Arthropathy (HP:0003040) | 2.04640600 |
| 97 | Flat acetabular roof (HP:0003180) | 2.04297164 |
| 98 | Genu recurvatum (HP:0002816) | 2.04115587 |
| 99 | Hypercholesterolemia (HP:0003124) | 2.02452532 |
| 100 | Hyperammonemia (HP:0001987) | 2.02118632 |
| 101 | Focal segmental glomerulosclerosis (HP:0000097) | 2.01005681 |
| 102 | Abnormality of carpal bone ossification (HP:0006257) | 2.00530879 |
| 103 | Infertility (HP:0000789) | 1.97904662 |
| 104 | Dysostosis multiplex (HP:0000943) | 1.97619877 |
| 105 | Abnormality of the peritoneum (HP:0002585) | 1.96656298 |
| 106 | Hypoglycemic coma (HP:0001325) | 1.95733196 |
| 107 | Hepatocellular carcinoma (HP:0001402) | 1.95542882 |
| 108 | Hypophosphatemic rickets (HP:0004912) | 1.94523685 |
| 109 | Vascular calcification (HP:0004934) | 1.94175724 |
| 110 | Mucopolysacchariduria (HP:0008155) | 1.92543628 |
| 111 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.92543628 |
| 112 | Disproportionate tall stature (HP:0001519) | 1.91492347 |
| 113 | Camptodactyly of toe (HP:0001836) | 1.89563845 |
| 114 | Abnormal cartilage morphology (HP:0002763) | 1.88109380 |
| 115 | Amyloidosis (HP:0011034) | 1.87636050 |
| 116 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.86692881 |
| 117 | Vacuolated lymphocytes (HP:0001922) | 1.86177082 |
| 118 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.85949152 |
| 119 | Spinal rigidity (HP:0003306) | 1.85388763 |
| 120 | Conjunctival telangiectasia (HP:0000524) | 1.83546383 |
| 121 | Hemorrhage of the eye (HP:0011885) | 1.82146088 |
| 122 | Axonal loss (HP:0003447) | 1.81815407 |
| 123 | Type 1 muscle fiber predominance (HP:0003803) | 1.81449578 |
| 124 | Turricephaly (HP:0000262) | 1.80964960 |
| 125 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.80927151 |
| 126 | Back pain (HP:0003418) | 1.80842992 |
| 127 | Mesangial abnormality (HP:0001966) | 1.80760520 |
| 128 | Spastic diplegia (HP:0001264) | 1.80736586 |
| 129 | Spontaneous hematomas (HP:0007420) | 1.78863982 |
| 130 | Bifid scrotum (HP:0000048) | 1.78722026 |
| 131 | Generalized aminoaciduria (HP:0002909) | 1.77666880 |
| 132 | Hyperextensible skin (HP:0000974) | 1.76034367 |
| 133 | Atelectasis (HP:0100750) | 1.74869523 |
| 134 | Recurrent otitis media (HP:0000403) | 1.73537579 |
| 135 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.72904450 |
| 136 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.72904450 |
| 137 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.72904450 |
| 138 | Tetraparesis (HP:0002273) | 1.72449322 |
| 139 | Fat malabsorption (HP:0002630) | 1.72236368 |
| 140 | Increased cerebral lipofuscin (HP:0011813) | 1.71511517 |
| 141 | Abnormality of the Achilles tendon (HP:0005109) | 1.71053934 |
| 142 | Recurrent sinusitis (HP:0011108) | 1.66136398 |
| 143 | Cholecystitis (HP:0001082) | 1.63730184 |
| 144 | Abnormal gallbladder physiology (HP:0012438) | 1.63730184 |
| 145 | Abnormality of the acetabulum (HP:0003170) | 1.62479994 |
| 146 | Blue irides (HP:0000635) | 1.62025034 |
| 147 | Abnormal tarsal ossification (HP:0008369) | 1.60140565 |
| 148 | * Thrombophlebitis (HP:0004418) | 1.53898946 |
| 149 | Hyperbilirubinemia (HP:0002904) | 1.50479795 |
| 150 | Abnormal hand bone ossification (HP:0010660) | 1.50146082 |
| 151 | Abnormal ossification of hand bones (HP:0005921) | 1.48907020 |
| 152 | Joint swelling (HP:0001386) | 1.47004012 |
| 153 | Occipital encephalocele (HP:0002085) | 1.46359274 |
| 154 | Abnormality of methionine metabolism (HP:0010901) | 1.44864231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 4.45371481 |
| 2 | ERN1 | 3.78591881 |
| 3 | KDR | 3.11772612 |
| 4 | TRIB3 | 3.01918817 |
| 5 | MST4 | 2.83165015 |
| 6 | TIE1 | 2.64764194 |
| 7 | PKN2 | 2.61320425 |
| 8 | SIK1 | 2.50467309 |
| 9 | FGFR4 | 2.45810183 |
| 10 | PDGFRA | 2.35368496 |
| 11 | DDR2 | 2.21110306 |
| 12 | RIPK1 | 2.19122277 |
| 13 | MAP3K2 | 2.09429893 |
| 14 | TTN | 2.04473590 |
| 15 | EPHA3 | 2.00973762 |
| 16 | LATS1 | 1.94752436 |
| 17 | LMTK2 | 1.92593188 |
| 18 | NEK9 | 1.88904812 |
| 19 | MST1R | 1.88722615 |
| 20 | EIF2AK1 | 1.86660936 |
| 21 | TYK2 | 1.86591929 |
| 22 | PTK6 | 1.75523427 |
| 23 | BCR | 1.70242029 |
| 24 | ICK | 1.69256695 |
| 25 | CAMK1D | 1.68811804 |
| 26 | STK24 | 1.61170319 |
| 27 | EPHB1 | 1.60774114 |
| 28 | EPHB2 | 1.58888871 |
| 29 | JAK1 | 1.52520021 |
| 30 | MET | 1.52224263 |
| 31 | PAK4 | 1.47314563 |
| 32 | FRK | 1.47024939 |
| 33 | TGFBR1 | 1.47017063 |
| 34 | BCKDK | 1.46929336 |
| 35 | FER | 1.43114937 |
| 36 | MAP3K3 | 1.36194731 |
| 37 | BRSK2 | 1.33742416 |
| 38 | NTRK1 | 1.29898929 |
| 39 | STK10 | 1.19787723 |
| 40 | LRRK2 | 1.19230522 |
| 41 | FLT3 | 1.18613902 |
| 42 | CDK6 | 1.15695855 |
| 43 | TBK1 | 1.15505139 |
| 44 | BMX | 1.14395787 |
| 45 | MAP3K12 | 1.14221949 |
| 46 | FGFR2 | 1.12320705 |
| 47 | LATS2 | 1.08689295 |
| 48 | EPHA2 | 1.08064943 |
| 49 | PTK2 | 1.07880941 |
| 50 | PAK2 | 1.07849288 |
| 51 | MAP3K6 | 1.07504018 |
| 52 | PDK2 | 1.04995889 |
| 53 | MAPK15 | 1.04918913 |
| 54 | FGFR3 | 1.04883420 |
| 55 | CSF1R | 1.04703476 |
| 56 | STK3 | 1.01012222 |
| 57 | BLK | 0.99171129 |
| 58 | CSK | 0.98292915 |
| 59 | MKNK2 | 0.97482679 |
| 60 | MAP2K3 | 0.96940454 |
| 61 | TRPM7 | 0.93186440 |
| 62 | RPS6KA4 | 0.92393915 |
| 63 | FGFR1 | 0.89744370 |
| 64 | ERBB4 | 0.88500196 |
| 65 | PDPK1 | 0.87926069 |
| 66 | PDGFRB | 0.87568786 |
| 67 | TAOK2 | 0.84904033 |
| 68 | JAK2 | 0.84502309 |
| 69 | CAMK1G | 0.83121027 |
| 70 | STK38L | 0.81751240 |
| 71 | MOS | 0.81578812 |
| 72 | GSK3A | 0.80535666 |
| 73 | KIT | 0.80027145 |
| 74 | PRKACG | 0.78742731 |
| 75 | PIK3CG | 0.77421351 |
| 76 | MAP3K5 | 0.76724913 |
| 77 | MAPKAPK3 | 0.75845823 |
| 78 | JAK3 | 0.75741388 |
| 79 | ABL2 | 0.74838986 |
| 80 | PTK2B | 0.71365768 |
| 81 | IGF1R | 0.71332954 |
| 82 | SCYL2 | 0.68463714 |
| 83 | NLK | 0.66757589 |
| 84 | NTRK3 | 0.66410612 |
| 85 | MAP2K1 | 0.65873206 |
| 86 | MTOR | 0.64270680 |
| 87 | ERBB3 | 0.63007541 |
| 88 | MYLK | 0.62247521 |
| 89 | MAPK12 | 0.59480908 |
| 90 | RET | 0.55666398 |
| 91 | ILK | 0.54272099 |
| 92 | EGFR | 0.53447639 |
| 93 | INSRR | 0.52615942 |
| 94 | ZAP70 | 0.52551517 |
| 95 | CDC42BPA | 0.51968317 |
| 96 | INSR | 0.50577985 |
| 97 | MAP3K14 | 0.50313085 |
| 98 | MAPK7 | 0.49150986 |
| 99 | MAPK11 | 0.49139944 |
| 100 | MAP3K1 | 0.48969018 |
| 101 | STK38 | 0.48962992 |
| 102 | DYRK1B | 0.48929395 |
| 103 | ROCK2 | 0.47511221 |
| 104 | MAP3K7 | 0.47380775 |
| 105 | PRKD1 | 0.46052799 |
| 106 | ERBB2 | 0.45677597 |
| 107 | KSR2 | 0.45377753 |
| 108 | IKBKB | 0.44108480 |
| 109 | MAP3K10 | 0.43877427 |
| 110 | YES1 | 0.42327112 |
| 111 | PRKAA2 | 0.42308551 |
| 112 | CHUK | 0.41844654 |
| 113 | MAP2K2 | 0.40071538 |
| 114 | PRKG1 | 0.39799654 |
| 115 | PRKG2 | 0.39760975 |
| 116 | AKT3 | 0.38669516 |
| 117 | HCK | 0.38628818 |
| 118 | ABL1 | 0.37869646 |
| 119 | PIK3CA | 0.37482547 |
| 120 | SGK3 | 0.37421396 |
| 121 | EEF2K | 0.37410661 |
| 122 | MUSK | 0.36308785 |
| 123 | ROCK1 | 0.36304385 |
| 124 | OBSCN | 0.36199106 |
| 125 | PRKCE | 0.34568020 |
| 126 | MAP3K11 | 0.34428642 |
| 127 | PRKCH | 0.34387442 |
| 128 | SGK494 | 0.34338056 |
| 129 | SGK223 | 0.34338056 |
| 130 | MATK | 0.34115452 |
| 131 | DMPK | 0.34008370 |
| 132 | CAMKK2 | 0.33893735 |
| 133 | PAK3 | 0.33131150 |
| 134 | CAMK2G | 0.32283008 |
| 135 | SGK2 | 0.31532345 |
| 136 | PIM2 | 0.30997809 |
| 137 | BMPR2 | 0.29862196 |
| 138 | SRC | 0.29615007 |
| 139 | NUAK1 | 0.27708783 |
| 140 | MAPKAPK2 | 0.27417294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.71873101 |
| 2 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.58411243 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.49025339 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.48783249 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.59379475 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.50631424 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.44646978 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.19099678 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.07887548 |
| 10 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.95049972 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.94831545 |
| 12 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.93091140 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.91602128 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.74811043 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.58058084 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.57881145 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.51109347 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.49913421 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.47981391 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.46117048 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.40452491 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.40324432 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.39376617 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.36523677 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.29074692 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.29012027 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.27858932 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.22483076 |
| 29 | Focal adhesion_Homo sapiens_hsa04510 | 1.22314468 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.21610361 |
| 31 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.18424386 |
| 32 | Prion diseases_Homo sapiens_hsa05020 | 1.18220658 |
| 33 | Amoebiasis_Homo sapiens_hsa05146 | 1.15158786 |
| 34 | Lysosome_Homo sapiens_hsa04142 | 1.13543953 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.12113247 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.11722834 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.07915017 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.07874126 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.06438720 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.05339711 |
| 41 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.04662069 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.00204238 |
| 43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.99290799 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.95450347 |
| 45 | Adherens junction_Homo sapiens_hsa04520 | 0.93141667 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.91613901 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 0.89022950 |
| 48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88470669 |
| 49 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.85404807 |
| 50 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85092746 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.84906172 |
| 52 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83797047 |
| 53 | Lysine degradation_Homo sapiens_hsa00310 | 0.81861808 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.81582000 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.80428159 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.80186854 |
| 57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.79776435 |
| 58 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.78174836 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77926678 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.73287008 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68094821 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66142793 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.63363253 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.63136889 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61076742 |
| 66 | Carbon metabolism_Homo sapiens_hsa01200 | 0.59693252 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59397943 |
| 68 | Leishmaniasis_Homo sapiens_hsa05140 | 0.59373449 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59268338 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58715747 |
| 71 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.58643716 |
| 72 | Legionellosis_Homo sapiens_hsa05134 | 0.58099123 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57645458 |
| 74 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.56771947 |
| 75 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.55654261 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.54472414 |
| 77 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.54201692 |
| 78 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.54165134 |
| 79 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.54054731 |
| 80 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.53985484 |
| 81 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.53455962 |
| 82 | Bladder cancer_Homo sapiens_hsa05219 | 0.53240767 |
| 83 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.53038613 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52594158 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48738835 |
| 86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47247459 |
| 87 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.45355784 |
| 88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45013604 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44414152 |
| 90 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44131367 |
| 91 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.42279393 |
| 92 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.40714267 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39584538 |
| 94 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.38129172 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38047672 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.37363468 |
| 97 | Platelet activation_Homo sapiens_hsa04611 | 0.36964678 |
| 98 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.35811806 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.35043931 |
| 100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.33514647 |
| 101 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.33463865 |
| 102 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33258567 |
| 103 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.33253431 |
| 104 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33226842 |
| 105 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.32629859 |
| 106 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.32470702 |
| 107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.32189916 |
| 108 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31917440 |
| 109 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.30461546 |
| 110 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.29431302 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29181471 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28749129 |
| 113 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.28677055 |
| 114 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27800888 |
| 115 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.26449635 |
| 116 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.25339695 |
| 117 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25055521 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24244576 |
| 119 | Circadian rhythm_Homo sapiens_hsa04710 | 0.19565624 |
| 120 | Mineral absorption_Homo sapiens_hsa04978 | 0.18125876 |
| 121 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.14526512 |
| 122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12576341 |
| 123 | Tight junction_Homo sapiens_hsa04530 | 0.12515396 |
| 124 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.09754318 |
| 125 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.08994080 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.04369678 |
| 127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.03865617 |

